These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 38382)
1. Pharmacokinetics and tolerability of a single oral 600-mg dose of doxycycline. Marlin GE; Cheng S Med J Aust; 1979 Jun; 1(12):575-6. PubMed ID: 38382 [TBL] [Abstract][Full Text] [Related]
2. Sputum and plasma doxycycline concentrations after a single oral 600 mg doxycycline dose in patients with chronic bronchitis. Marlin GE; Cheng S; Thompson PJ Eur J Respir Dis; 1981 Aug; 62(4):276-80. PubMed ID: 7308339 [TBL] [Abstract][Full Text] [Related]
3. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095 [TBL] [Abstract][Full Text] [Related]
4. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease. Conte JE; Golden JA; McIver M; Little E; Zurlinden E Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to tetracycline and doxycycline in clinical isolates of Haemophilus influenzae. Ringertz S; Dornbusch K Scand J Infect Dis Suppl; 1988; 53():7-11. PubMed ID: 3262234 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study. Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemia. Wójcicki J; Kalinowski W; Gawrońska-Szklarz B Arzneimittelforschung; 1985; 35(6):991-3. PubMed ID: 4026928 [TBL] [Abstract][Full Text] [Related]
8. [Doxycycline pellets: a suitable formulation with guaranteed bioequivalence]. Hampel B; Lode H; Fenner H; Gikalov I Arzneimittelforschung; 1980; 30(11):1938-43. PubMed ID: 7193007 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
10. The absorption and sputum penetration of doxycycline. MacArthur CG; Johnson AJ; Chadwick MV; Wingfield HJ J Antimicrob Chemother; 1978 Nov; 4(6):509-14. PubMed ID: 30746 [No Abstract] [Full Text] [Related]
11. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis. Renkonen OV Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377 [TBL] [Abstract][Full Text] [Related]
13. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects. O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550 [TBL] [Abstract][Full Text] [Related]
15. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren. Jain A; Kumar P; Awasthi S Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. Davis JL; Salmon JH; Papich MG Am J Vet Res; 2006 Feb; 67(2):310-6. PubMed ID: 16454638 [TBL] [Abstract][Full Text] [Related]
17. Doxycycline blood levels in normal subjects after intravenous and oral administration. Leibowitz BJ; Hakes JL; Cahn MM; Levy EJ Curr Ther Res Clin Exp; 1972 Dec; 14(12):820-32. PubMed ID: 4629823 [No Abstract] [Full Text] [Related]
18. Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. A clinical study. Gnarpe H; Dornbusch K; Hägg O Scand J Infect Dis Suppl; 1976; (9):54-7. PubMed ID: 795010 [TBL] [Abstract][Full Text] [Related]
19. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects. Mant T; Jurcevic S; Szakacs C; Adams L; Boland J; Hewitt LA Clin Ther; 2008 Jan; 30(1):131-42. PubMed ID: 18343249 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]